Jessica Elizabeth Taylor

Affiliations: 
ATR Computational Neuroscience Laboratories, Stoke-on-Trent, England, United Kingdom 
Area:
DecNef, fMRI, Computational Neuroscience, Behavioral Neuroscience
Google:
"Jessica Taylor"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Clarke K, Borges K, Hatab S, et al. (2024) Ethical considerations related to virtual visiting for families and critically ill patients in intensive care: a qualitative descriptive study. Bmc Medical Ethics. 25: 126
Lilie TJ, Bouzy J, Asundi A, et al. (2024) HIV-1 latency reversal agent boosting is not limited by opioid use. Jci Insight
Mandolfo O, Parker H, Aguado È, et al. (2024) Systemic immune challenge exacerbates neurodegeneration in a model of neurological lysosomal disease. Embo Molecular Medicine
Nottke A, Alan S, Brimble E, et al. (2024) Validation and clinical discovery demonstration of breast cancer data from a real-world data extraction platform. Jamia Open. 7: ooae041
Hodges ZH, Bright M, Carpenter AM, et al. (2024) Obesity and Associated Outcomes for Blunt vs Penetrating Mechanism in Trauma Laparotomy Patients. The American Surgeon. 31348241241725
Ellison S, Liao A, Gleitz HFE, et al. (2023) Sustained long-term disease correction in a murine model of MPSII following stem cell gene therapy. Molecular Therapy. Methods & Clinical Development. 31: 101127
Regalbuto E, Stone A, Taylor J, et al. (2023) Understanding the Strengths and Limitations of Current Methods for Surveying Partner Nation Medical Facilities. Military Medicine
Yango A, Bista B, Fischbach B, et al. (2023) Elevated tacrolimus levels among COVID-19 kidney transplant recipients are associated with worse disease severity and clinical outcomes. Clinical Nephrology
Lilie T, Bouzy J, Asundi A, et al. (2023) Opioid use does not limit potent low-dose HIV-1 latency reversal agent boosting. Medrxiv : the Preprint Server For Health Sciences
Shaw DE, Smith N, Beerli R, et al. (2023) Design and Synthesis of Inhibitors of the E3 Ligase SMAD Specific E3 Ubiquitin Protein Ligase 1 as a Treatment for Lung Remodeling in Pulmonary Arterial Hypertension. Journal of Medicinal Chemistry
See more...